Literature DB >> 18628789

Deciphering the genetics of hereditary non-syndromic colorectal cancer.

Eli Papaemmanuil1, Luis Carvajal-Carmona, Gabrielle S Sellick, Zoe Kemp, Emily Webb, Sarah Spain, Kate Sullivan, Ella Barclay, Steven Lubbe, Emma Jaeger, Jayaram Vijayakrishnan, Peter Broderick, Maggie Gorman, Lynn Martin, Anneke Lucassen, D Timothy Bishop, D Gareth Evans, Eamonn R Maher, Verena Steinke, Nils Rahner, Hans K Schackert, Timm O Goecke, Elke Holinski-Feder, Peter Propping, Tom Van Wezel, Juul Wijnen, Jean-Baptiste Cazier, Huw Thomas, Richard S Houlston, Ian Tomlinson.   

Abstract

Previously we have localized to chromosome 3q21-q24, a predisposition locus for colorectal cancer (CRC), through a genome-wide linkage screen (GWLS) of 69 families without familial adenomatous polyposis or hereditary non-polyposis CRC. To further investigate Mendelian susceptibility to CRC, we extended our screen to include a further GWLS of an additional 34 CRC families. We also searched for a disease gene at 3q21-q24 by linkage disequilibrium mapping in 620 familial CRC cases and 960 controls by genotyping 1676 tagging SNPs and sequencing 30 candidate genes from the region. Linkage analysis was conducted using the Affymetrix 10K SNP array. Data from both GWLSs were pooled and multipoint linkage statistics computed. The maximum NPL score (3.01; P=0.0013) across all families was at 3q22, maximal evidence for linkage coming from families segregating rectal CRC. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a dominant model (HLOD=2.79; P=0.00034), with an estimated 43% of families linked. In the case-control analysis, the strongest association was obtained at rs698675 (P=0.0029), but this was not significant after adjusting for multiple testing. Analysis of candidate gene mapping to the region of maximal linkage on 3q22 failed to identify a causal mutation. There was no evidence for linkage to the previously reported 9q CRC locus (NPL=0.95, P=0.23; HLOD(dominant)=0.40, HLOD(recessive)=0.20). Our findings are consistent with the hypothesis that variation at 3q22 contributes to the risk of CRC, but this is unlikely to be mediated through a restricted set of alleles.

Entities:  

Mesh:

Year:  2008        PMID: 18628789     DOI: 10.1038/ejhg.2008.129

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.

Authors:  Mehrdad Zeinalian; Mohammad Hassan Emami; Rasoul Salehi; Azar Naimi; Mohammad Kazemi; Morteza Hashemzadeh-Chaleshtori
Journal:  J Gastrointest Cancer       Date:  2015-06

2.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

Review 3.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.

Authors:  Ian W Saunders; Jason Ross; Finlay Macrae; Graeme P Young; Ignacio Blanco; Jesper Brohede; Glenn Brown; Diana Brookes; Trevor Lockett; Peter L Molloy; Victor Moreno; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

5.  Bayesian mixture models for the incorporation of prior knowledge to inform genetic association studies.

Authors:  Brooke L Fridley; Daniel Serie; Gregory Jenkins; Kristin White; William Bamlet; John D Potter; Ellen L Goode
Journal:  Genet Epidemiol       Date:  2010-07       Impact factor: 2.135

6.  Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Authors:  Rosa M Xicola; Sneha Bontu; Brian J Doyle; Jamie Rawson; Pilar Garre; Esther Lee; Miguel de la Hoya; Xavier Bessa; Joan Clofent; Luis Bujanda; Francesc Balaguer; Sergi Castellví-Bel; Cristina Alenda; Rodrigo Jover; Clara Ruiz-Ponte; Sapna Syngal; Montserrat Andreu; Angel Carracedo; Antoni Castells; Polly A Newcomb; Noralane Lindor; John D Potter; John A Baron; Nathan A Ellis; Trinidad Caldes; Xavier LLor
Journal:  Carcinogenesis       Date:  2016-05-27       Impact factor: 4.944

7.  Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.

Authors:  E Sánchez-Tomé; B Rivera; J Perea; G Pita; D Rueda; F Mercadillo; A Canal; A Gonzalez-Neira; J Benitez; M Urioste
Journal:  J Gastroenterol       Date:  2014-11-09       Impact factor: 7.527

Review 8.  Molecular origins of cancer: Molecular basis of colorectal cancer.

Authors:  Sanford D Markowitz; Monica M Bertagnolli
Journal:  N Engl J Med       Date:  2009-12-17       Impact factor: 91.245

9.  Identification of patients at risk for hereditary colorectal cancer.

Authors:  Nitin Mishra; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2012-06

10.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).

Authors:  Aedan Roberts; Derek Nancarrow; Mark Clendenning; Daniel D Buchanan; Mark A Jenkins; David Duggan; Darin Taverna; Diane McKeone; Rhiannon Walters; Michael D Walsh; Bruce W Young; Jeremy R Jass; Christophe Rosty; Michael Gattas; Elise Pelzer; John L Hopper; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry Phillips; Susan Parry; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Musa Drini; Finlay Macrae; Polly Newcomb; John D Potter; Erika Pavluk; Annika Lindblom; Joanne P Young
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.